Lung Cancer, Pulmonary Nodule
Conditions
Interventions
Population-based cohort of lung cancer in community:LDCT screening
Population-based cohort study of lung cancer in high risk areas:lung examination
Cohort study of standardized clinical diagnosis and treatment for lung cancer: Standardized clinical diagnosis and treatment for lung cancer
Cohort study of individual clinical research for lung cancer:Individual clinical treatment for lung cancer
Cohort study of molecular markers detection for recurrence and metastasis of lung cancer:Molecular markers detection
Sponsors
Cancer Hospital Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Population-based cohort of lung cancer in community: population with high risk of lung cancer; 2. Population-based cohort study of lung cancer in high risk areas: population from high risk areas and exposed to specific risk factors; 3. Cohort study of standardized clinical diagnosis and treatment for lung cancer: patients newly diagnosed with lung cancer and standardized clinical treated; 4. Cohort study of individual clinical research for lung cancer: late stage lung cancer and individualized treated; 5. Cohort study of molecular markers detection for recurrence and metastasis of lung cancer: patients with recurrence or metastasis, and received biomarker detection.
Exclusion criteria
Exclusion criteria: 1. Subjects diagnosed with other cancer; 2. Individuals with history of other severe diseases; 3. Individuals who are unwilling to sign the consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| loss to follow up rate;completion rate of cohort establishment; | — |
Countries
China
Contacts
Public ContactMin Dai
Cancer Hospital Chinese Academy of Medical Sciences
Outcome results
None listed